NCT04362787

Brief Summary

High pressure NIV is a pressure limited ventilation, stating IPAP pressure at 20 cmH2O and gradually increasing pressure up to 30 cmH2O according to patient tolerance.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2020

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 27, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

July 13, 2020

Status Verified

July 1, 2020

Enrollment Period

1.7 years

First QC Date

April 23, 2020

Last Update Submit

July 10, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • High pressure non invasive ventilation in acute hypercapnic respiratory failure

    To study the efficacy of safety of high pressure NIV in acute hypercapnic respiratory failure due to COPD and obesity hypoventilation syndrome who refractory to low pressure NIV.

    Patients will assessed after 2 hours from increasing pressure

  • High pressure non invasive ventilation in acute hypercapnic respiratory failure

    Effect of high pressure NIV on length of hospital stay , need for invasive mechanical ventilation, mortality.

    Patients will assessed after 2 hours from increasing pressure

Study Arms (1)

High pressure _ low pressure non-invasive ventilation

In the high-pressure NIV,52 patients will undergo pressure-limited NPPV at a higher IPAP level. IPAP is initially set at 20 cmH2O and continuously adjusted by increments and decrements of 1-2 cmH2O (up to 30 cmH2O), according to patients' tolerance, to obtain a tidal volume (VT) of 15 mL/kg of IBW. 2- EPAP for patients with COPD will be started at EPAP 5 and will be increased till 7 and for the patients with hypoventilation syndrome will be increased up to EPAP 8. 3-Respiratory rate 10-12 b/min.

Device: High pressure non invasive ventilation in acute hypercapnic respiratory failure

Interventions

Usage of High pressure non invasive ventilation in acute hypercapnic respiratory failure

High pressure _ low pressure non-invasive ventilation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who failed on low pressure NIV will be shifted to high pressure NIV with any of these

You may qualify if:

  • All patients admitted in Assiut University Hospital and Assiut Police Hospital with acute hypercapnic respiratory failure due to COPD and Obesity hypoventilation syndrome (OHS) indicated for conventional NIV.
  • Patients who failed on low pressure NIV will be shifted to high pressure NIV with any of these conditions:
  • PH \<7.30 or less than admission level.
  • RR \> 35b/m or more than admission level.
  • SpO2 \< 88%.

You may not qualify if:

  • Age \<18 years.
  • Excessive amount of respiratory secretions or weak cough.
  • Upper airway obstruction.
  • Recent oral, facial or cranial trauma or surgery.
  • Sever abdominal distension.
  • Active upper gastrointestinal bleeding.
  • Cardiac or respiratory arrest.
  • PH\<7.25.
  • Arterial oxygen tension /fraction of inspired oxygen (PaO2 / FiO2) \<150mmHg.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Khaled Hu Ahmed

    Professor of chest diseases Faculty of medicine Assiut university

    STUDY DIRECTOR

Central Study Contacts

Maha Ei Abdelhafeez, Master

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

April 23, 2020

First Posted

April 27, 2020

Study Start

August 1, 2020

Primary Completion

April 1, 2022

Study Completion

April 1, 2023

Last Updated

July 13, 2020

Record last verified: 2020-07